32.jpg)
56.jpg)
TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER
Patent number:
WO21009029
No items found.
Compounds of formula (I) of the betaxanthin family, or pharmaceutical compositions comprising the same, for use in the treatment and/or prevention of cancer and/or tumours, are described. In addition, the use of nutraceutical compositions, for the prevention of cancer or as chemopreventive compositions, comprising said compounds of formula (I) is described.
Countries:
Spain
Regions:
Region of Murcia
Centers:
UNIVERSIDAD DE MURCIA
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals, Organic fine chemistry
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
- Obtaining larger amounts of betaxanthins compared to other methods used. - Obtaining pure betaxanthins with antitumor properties tested in the C. Elegans animal model.
Comments
Other related patents
Health
DEVICE FOR EVALUATING, MONITORING AND CONTROLLING THE FORCE EXERTED ON CLIMBING HOLDS DURING CLIMBING
Health
MICROSCOPE FOR NON-INVASIVE, REAL-TIME DIAGNOSIS OF DIABETES
Health